Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

70.1K
Overview
70.1K
Karyotyping01:17

Karyotyping

12.0K
12.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.4K
3.4K
Tumor Progression02:07

Tumor Progression

7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Annals of hematology·2026
Same author

Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

British journal of haematology·2026
Same author

Production and characterization of norovirus virus-like particles vaccine candidates in a genetically modified Ogataea minuta system.

Journal of bioscience and bioengineering·2025
Same author

Case Report: Immunophenotypically diverse immature patterns, including variable TdT expression, in aggressive B-cell lymphomas and leukemia with <i>MYC</i> rearrangement.

Frontiers in oncology·2025
Same author

Optimization of heterologous protein production process using genetically engineered Ogataea minuta toward industrial-scale manufacturing.

Journal of bioscience and bioengineering·2025
Same author

Autologous stem cell transplantation from 2011 to 2022 in Japanese patients aged ≥ 65 years with relapsed or refractory diffuse large B-cell lymphoma.

Annals of hematology·2025

Related Experiment Video

Updated: Apr 3, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.9K

Karyotype evolution of multiple myeloma.

Yosuke Matsumoto1, Tsuyoshi Ichimura2, Junichi Harukawa2

  • 1Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.

Journal of Clinical and Experimental Hematopathology : JCEH
|April 1, 2026
PubMed
Summary

This study visualizes multiple myeloma (MM) karyotype evolution using phylogenetic trees. G-banding analysis revealed complex chromosomal changes, offering insights into cancer progression.

Keywords:
G-bandingkaryotype evolutionmultiple myelomaphylogenetic tree

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.6K
Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

84.5K

Related Experiment Videos

Last Updated: Apr 3, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.9K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.6K
Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

84.5K

Area of Science:

  • Genetics
  • Oncology
  • Cell Biology

Background:

  • Multiple myeloma (MM) is a cancer of plasma cells.
  • Understanding karyotype evolution is crucial for MM pathogenesis.
  • Previous studies have not fully elucidated the complex evolutionary pathways in MM.

Purpose of the Study:

  • To clarify the karyotype evolution of multiple myeloma (MM).
  • To depict karyotype evolutions as phylogenetic trees.
  • To identify common chromosomal abnormalities and their roles in MM progression.

Main Methods:

  • Analysis of multiple karyotypes from 22 MM patients using G-banding.
  • Construction of phylogenetic trees to visualize karyotype evolution.
  • Identification and characterization of chromosomal structural abnormalities and aneuploidies.

Main Results:

  • Eleven patients showed complex karyotype evolutions, including branched, linear, parallel, and macroevolution.
  • Chromosomal structural abnormalities involving 14q32 were frequently observed at the root of evolutionary trees.
  • Aneuploidies and other structural abnormalities were present in initial clones and evolved subclones, potentially arising from unequal segregation or whole-chromosome doubling.
  • Four patients had distinct karyotype abnormalities associated with myelodysplastic syndrome.

Conclusions:

  • Phylogenetic trees generated by G-banding effectively illustrate the karyotype evolution in multiple myeloma.
  • Chromosomal abnormalities involving 14q32 appear early in MM evolution.
  • Aneuploidies play a significant role throughout MM progression, with specific mechanisms identified.